Belpointe Asset Management’s PGIM Ultra Short Bond ETF PULS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$908K Buy
18,329
+1,838
+11% +$91.2K 0.03% 521
2026
Q1
$816K Sell
16,491
-63,787
-79% -$3.17M 0.03% 529
2025
Q4
$3.98M Sell
80,278
-675
-0.8% -$33.6K 0.14% 114
2025
Q3
$4.03M Sell
80,953
-107,526
-57% -$5.35M 0.15% 113
2025
Q2
$9.38M Buy
188,479
+29,209
+18% +$1.45M 0.39% 48
2025
Q1
$7.92M Buy
159,270
+28,765
+22% +$1.43M 0.41% 40
2024
Q4
$6.5M Sell
130,505
-2,326
-2% -$116K 0.39% 45
2024
Q3
$6.61M Sell
132,831
-9,280
-7% -$461K 0.4% 42
2024
Q2
$7.06M Buy
142,111
+82,368
+138% +$4.09M 0.49% 31
2024
Q1
$2.97M Buy
59,743
+48,026
+410% +$2.38M 0.22% 100
2023
Q4
$579K Buy
+11,717
New +$579K 0.05% 327

Other funds holding PULS

Belpointe Asset Management's PULS Position: Q2 2026 in Review

Belpointe Asset Management increased its PGIM Ultra Short Bond ETF (PULS) stake by 11% in Q2 2026, buying an estimated $91.2K and bringing the position to 18,329 shares worth $908K. The position accounts for 0.03% of the portfolio, ranked #521.

Belpointe Asset Management first reported a position in PULS in Q4 2023 and has held it in 11 quarters since. The position peaked at $9.38M in Q2 2025. 471 funds tracked by Wall St. Rank hold PULS as of Q2 2026.

  • Belpointe Asset Management held 18,329 shares of PGIM Ultra Short Bond ETF worth $908K as of Q2 2026.
  • Belpointe Asset Management bought 1,838 PGIM Ultra Short Bond ETF shares in Q2 2026, an estimated $91.2K.
  • PGIM Ultra Short Bond ETF made up 0.03% of Belpointe Asset Management's portfolio in Q2 2026, its #521 holding.
  • Belpointe Asset Management first reported a position in PGIM Ultra Short Bond ETF in Q4 2023 and has held it in 11 quarters since.
  • Belpointe Asset Management's PGIM Ultra Short Bond ETF position peaked at $9.38M in Q2 2025.
  • 471 funds tracked by Wall St. Rank held PGIM Ultra Short Bond ETF as of Q2 2026.

Based on Belpointe Asset Management's 13F filing for Q2 2026, filed 31 Jul 2026.